Keppra and Haloperidol lactate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Haloperidol lactate (haloperidol lactate). Common drug interactions include cerebellar atrophy among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Haloperidol lactate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Haloperidol lactate?

Haloperidol lactate has active ingredients of haloperidol lactate. eHealthMe is studying from 606 Haloperidol lactate users. Check the latest studies of Haloperidol lactate.



On Jul, 10, 2026

11 people who take Keppra and Haloperidol lactate together, and have interactions are studied.

Keppra and Haloperidol lactate drug interactions.

What are the common drug interactions of Keppra and Haloperidol Lactate, by gender? *:

female:

n/a

male:

  1. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  2. Dystonia (abnormal muscle tone)
  3. Dyspnoea (difficult or laboured respiration)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypotension (abnormally low blood pressure)
  6. Leukocytosis (increased white blood cells)
  7. Nausea (feeling of having an urge to vomit)
  8. Platelet count decreased
  9. Renal failure chronic (long lasting kidney dysfunction)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Keppra and Haloperidol Lactate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  2. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans)

40-49:

  1. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  2. Dystonia (abnormal muscle tone)
  3. Electrolyte imbalance
  4. Emotional disorder
  5. Eye disorder
  6. Insomnia (sleeplessness)
  7. Limb injury
  8. Migraine (headache)
  9. Speech disorder
  10. Fall

50-59:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

60+:

  1. Bradycardia (abnormally slow heart action)
  2. Dyspnoea (difficult or laboured respiration)
  3. Anaemia (lack of blood)
  4. Lung infection pseudomonal (bacterial infection of lung by pseudomonas aeruginosa)
  5. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Cough
  8. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 45.45%
  2. Pain: 5 people, 45.45%
  3. Constipation: 5 people, 45.45%
  4. Agitation (state of anxiety or nervous excitement): 5 people, 45.45%
  5. Psychotic Disorder: 4 people, 36.36%
  6. Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 2 people, 18.18%
  7. Bone Marrow Conditioning Regimen: 2 people, 18.18%
  8. Stress And Anxiety: 1 person, 9.09%
  9. Nausea (feeling of having an urge to vomit): 1 person, 9.09%
  10. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Haloperidol lactate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keppra and Haloperidol lactate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Haloperidol lactate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Haloperidol lactate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and haloperidol lactate (the active ingredients of Keppra and Haloperidol lactate, respectively), and Keppra and Haloperidol lactate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: